advertisement
Liu S 35
Showing records 1 to 25 | Display all abstracts from Liu S96185 Genetic association between CDKN2B-AS1 polymorphisms and the susceptibility of primary open-angle glaucoma (POAG): a meta-analysis from 21,775 subjects
Liu S
Irish journal of medical science 2022; 191: 2385-2392
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Rayana NP
Investigative Ophthalmology and Visual Science 2021; 62: 7
96104
Xiao D; Jin K
Frontiers in cell and developmental biology 2021; 9: 755544
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Sugali CK
Investigative Ophthalmology and Visual Science 2021; 62: 7
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Han X
Drug Delivery 2021; 28: 2011-2023
96185 Genetic association between CDKN2B-AS1 polymorphisms and the susceptibility of primary open-angle glaucoma (POAG): a meta-analysis from 21,775 subjects
Chen S
Irish journal of medical science 2022; 191: 2385-2392
96104
Qiu S
Frontiers in cell and developmental biology 2021; 9: 755544
96185 Genetic association between CDKN2B-AS1 polymorphisms and the susceptibility of primary open-angle glaucoma (POAG): a meta-analysis from 21,775 subjects
Niu T
Irish journal of medical science 2022; 191: 2385-2392
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Li H
Drug Delivery 2021; 28: 2011-2023
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Dai J
Investigative Ophthalmology and Visual Science 2021; 62: 7
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Tao Q
Drug Delivery 2021; 28: 2011-2023
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Peng M
Investigative Ophthalmology and Visual Science 2021; 62: 7
96104
Lei Q
Frontiers in cell and developmental biology 2021; 9: 755544
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Hu J
Drug Delivery 2021; 28: 2011-2023
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Liu S
Investigative Ophthalmology and Visual Science 2021; 62: 7
96104
Huang W
Frontiers in cell and developmental biology 2021; 9: 755544
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Zhang Y
Investigative Ophthalmology and Visual Science 2021; 62: 7
96104
Chen H
Frontiers in cell and developmental biology 2021; 9: 755544
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Liu S; Liu H
Drug Delivery 2021; 28: 2011-2023
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Wan J
Investigative Ophthalmology and Visual Science 2021; 62: 7
96104
Su J
Frontiers in cell and developmental biology 2021; 9: 755544
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Zhou J
Drug Delivery 2021; 28: 2011-2023
95571 Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
Mao W
Investigative Ophthalmology and Visual Science 2021; 62: 7
96104
Xu Q
Frontiers in cell and developmental biology 2021; 9: 755544
96347 Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres
Li W
Drug Delivery 2021; 28: 2011-2023
